PNC Financial Services Group
ABEO icon

PNC Financial Services Group’s Abeona Therapeutics ABEO Stock Holding History

PNC Financial Services Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15K Buy
2,864
+2,295
+403% +$14.2K ﹤0.01% 3992
2026
Q2 		$3.52K Buy
569
+483
+562% +$2.65K ﹤0.01% 4512
2026
Q1 		$385 Buy
86
+81
+1,620% +$405 ﹤0.01% 4968
2025
Q4 		$26 Sell
5
-477
-99% -$2.4K ﹤0.01% 5123
2025
Q3 		$2.54K Buy
+482
New +$3.06K ﹤0.01% 4436

Other funds holding ABEO

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Panagora Asset Management
Panagora Asset Management Boston, Massachusetts $33.2B AUM 43.67% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

PNC Financial Services Group's ABEO Position: Q3 2026 in Review

PNC Financial Services Group increased its Abeona Therapeutics (ABEO) stake by 403% in Q3 2026, buying an estimated $14.2K and bringing the position to 2,864 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #3992.

PNC Financial Services Group first reported a position in ABEO in Q3 2025 and has held it in 5 quarters since. 55 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

  • PNC Financial Services Group held 2,864 shares of Abeona Therapeutics worth $15K as of Q3 2026.
  • PNC Financial Services Group bought 2,295 Abeona Therapeutics shares in Q3 2026, an estimated $14.2K.
  • Abeona Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3992 holding.
  • PNC Financial Services Group first reported a position in Abeona Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • 55 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.